Comment on: Safinamide as adjunctive therapy for Parkinson's disease: A promising option with room for improvement

被引：0
|
作者：
Matovu, Daniel [1 ]
机构：
[1] Kabale Univ, Dept Clin Pharmacol & Therapeut, Kabale, Uganda
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2024年 / 462卷
关键词：
MAO-B inhibitor; Wearing-off; Parkinson's disease; Safinamide;
D O I：
10.1016/j.jns.2024.123103
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real life evaluation of safinamide effectiveness in Parkinson's disease
    Mancini, Francesca
    Di Fonzo, Alessio
    Lazzeri, Giulia
    Borellini, Linda
    Silani, Vincenzo
    Lacerenza, Marco
    Comi, Cristoforo
    NEUROLOGICAL SCIENCES, 2018, 39 (04) : 733 - 739
  • [22] The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease
    Abbruzzese, Giovanni
    Barone, Paolo
    Lopiano, Leonardo
    Stocchi, Fabrizio
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2507 - 2517
  • [23] Real life evaluation of safinamide effectiveness in Parkinson’s disease
    Francesca Mancini
    Alessio Di Fonzo
    Giulia Lazzeri
    Linda Borellini
    Vincenzo Silani
    Marco Lacerenza
    Cristoforo Comi
    Neurological Sciences, 2018, 39 : 733 - 739
  • [24] The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease
    Perez-Lloret, Santiago
    Rascol, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (03) : 245 - 258
  • [25] Safinamide: an add-on treatment for managing Parkinson's disease
    Mueller, Thomas
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 31 - 41
  • [26] The tolerability, safety and efficacy of safinamide in elderly Parkinson's disease patients: a retrospective study
    Rinaldi, Domiziana
    Bianchini, Edoardo
    Sforza, Michela
    Alborghetti, Marika
    Galli, Silvia
    Salvetti, Marco
    Giovannelli, Morena
    Pontieri, Francesco E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (06) : 1689 - 1692
  • [27] The tolerability, safety and efficacy of safinamide in elderly Parkinson’s disease patients: a retrospective study
    Domiziana Rinaldi
    Edoardo Bianchini
    Michela Sforza
    Marika Alborghetti
    Silvia Galli
    Marco Salvetti
    Morena Giovannelli
    Francesco E. Pontieri
    Aging Clinical and Experimental Research, 2021, 33 : 1689 - 1692
  • [28] Safinamide improves executive functions in fluctuating Parkinson's disease patients: an exploratory study
    Rinaldi, Domiziana
    Sforza, Michela
    Assogna, Francesca
    Savini, Cinzia
    Salvetti, Marco
    Caltagirone, Carlo
    Spalletta, Gianfranco
    Pontieri, Francesco E.
    JOURNAL OF NEURAL TRANSMISSION, 2021, 128 (02) : 273 - 277
  • [29] Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
    Caterina Pauletti
    Nicoletta Locuratolo
    Daniela Mannarelli
    Andrea Maffucci
    Alessia Petritis
    Elisa Menini
    Francesco Fattapposta
    Journal of Neural Transmission, 2023, 130 : 915 - 923
  • [30] Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease
    Espinoza-Vinces, Christian
    Villino-Rodriguez, Rafael
    Atorrasagasti-Villar, Ainhoa
    Marti-Andrea, Gloria
    Luquin, Maria-Rosario
    PATIENT-RELATED OUTCOME MEASURES, 2023, 14 : 285 - 295
12345